Načítá se...
Ibrutinib: A paradigm shift in management of CLL
B-cell receptor (BCR) signaling plays a vital role in B-cell malignancies; Bruton's Tyrosine Kinase (BTK) is a critical mediator of this signaling. BCR signaling, either constitutively or following antigen binding, leads to activation of several downstream pathways involved in cell survival, pr...
Uloženo v:
| Vydáno v: | Expert Rev Hematol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4811630/ https://ncbi.nlm.nih.gov/pubmed/25387837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17474086.2014.977862 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|